Hot Topics

Applied DNA Sciences

Newsletters June 21, 2019

No. 416: An SBU president, a Habitat Suffolk milestone, and raising a Glassdoor to Island CEOs

  Spring forward: And maybe add a somersault, dear readers, as we vault into summer – and leap into the waiting arms of another well-earned weekend. It’s Friday, June 21, and to our readers in the Southern Hemisphere, bundle up. The solstice with the mostess: Of course, that means it’s the summer solstice for us northerners – the longest day of the year (daylight-wise), New Year’s Day (for ancient Egyptians) and chock full of other…

Newsletters June 19, 2019

No. 415: On Cheerios, Stooges, smarter schools and ignored internships – plus, action in Innovation Park 

  Sunny disposition: Welcome to Wednesday, dear readers, and the final Innovate LI newsletter of Spring 2019. That’s correct – whatever soggy gloom the Weather Channel predicts, summer officially begins Friday. And of course, the innovation forecast is always warm and bright in here. Pista Y ang Kagueban: It’s June 19 out there, and before we dive in, welcome new newsletter subscribers Frank, James, Leslie, Robert, Philip, Naraj, Thomas, Peter, Rachel, Glenn, Nina, Sarah, Louis…

Earnings June 18, 2019

Nathan’s relishes hot fiscal year, topped by big 4Q

  NATHAN’S FAMOUS INC. Headquarters: Jericho Industry: Consumer services Nasdaq: NATH Reporting Date: June 14, 2019 Reporting Quarter: 4Q FY2019 Quarter Ended: March 31, 2019 Numbers: Reported revenues for the fourth quarter were $22.1 million, an 11-percent increase over the $19.9 million reported for the same quarter last fiscal year. Quarterly net income was reported as $2.49 million, light-years better than the $367,000 reported for 4Q FY2018, and earnings per diluted share followed, increasing year-over-year…

Biotech June 17, 2019

With synthetic opioids lurking, DNA detector scores

By GREGORY ZELLER // With synthetic opioids increasingly implicated in the alarming number of drug-overdose deaths plaguing the nation, a stalwart Long Island biotech’s DNA-based tracking technology has received a major endorsement. The peer-reviewed scientific journal PLOS ONE has published a paper by Stony Brook-based Applied DNA Sciences on the molecular tagging of pharmaceuticals – a next-gen supply-chain authenticator that Applied DNA considers unforgeable, inescapable and particularly useful in a world where counterfeit drugs are…

Newsletters May 17, 2019

No. 406: Building Bridgeworks, accentuating AI, big bucks in Bethpage – and only Applied DNA could go to China

  Finish line: The end of another busy workweek is upon is, dear readers, and the start of another well-earned weekend. It’s May 17 out there, and if you had the hometown Wallachians driving the invading Ottoman Empire out of southern Romania on this date in 1395’s Battle of Rovine, kudos – 150 silver groschen have been credited to your account. You say potato: Today is IDAHO, but it has nothing to do with Gem…

Newsletters April 5, 2019

No. 394: On cancer centers, secure weed and Asian affairs (plus: naughty books in Huntington)

  Don’t know how you do it: But you’ve done it again, dear reader – it’s Friday and you’re sprinting toward the finish line of another busy workweek, with another well-earned weekend in the offing. Nicely done. It’s April 5 out there, and if you had Alexander Nevsky’s Russian forces turning back the Teutonic Knights in the Battle on the Ice on this date in 1242, pozdravlyayu! The state gratefully collects 200 rubles on your…

Awards and Events March 27, 2019

Breakfast of champions

Hundreds turn out to honor LI’s brightest innovators (photos by Bob Giglione) In a rare breakfast networker that delivered all the feels, Innovate Long Island saluted its 2019 Innovators of the Year Tuesday at the Crest Hollow Country Club in Woodbury. More than 200 guests turned out to honor two dozen of Long Island’s brightest and boldest researchers, inventors, entrepreneurs and executives, including 2019 Master of Innovation Mitch Maiman and Stony Brook University Vice President…

Newsletters February 15, 2019

No. 381: The Spur evolves, MIDI steps up, Applied DNA in the weeds – and Amazon, we hardly knew ye

  Well done: It’s Friday, friends, and you’ve done it again – the end of the workweek is upon us and another welcomed weekend dawns. It’s Feb. 15 out there, and it’s a busy one – Liberation Day in Afghanistan, National Flag Day in Canada, Statehood Day in Serbia, Total Defence Day in Singapore and, here in the States, Susan B. Anthony Day, celebrating the life and times of our national matriarch of women’s suffrage…

Biotech February 14, 2019

New licensing deal adds fresh buzz to joint venture

By GREGORY ZELLER // A partnership between a Stony Brook biotech and a Canadian pharmaceutical-solutions provider is growing like a weed. Less than a year since introducing the world’s first DNA-based cannabis-tagging system and just five months since they upgraded the system to accommodate large-scale growers, Applied DNA Sciences and Canadian/Panamanian cohort TheraCann International Benchmark Corp. have inked an exclusive licensing deal. The skinny: a long-term licensing agreement pairing Applied DNA’s proprietary CertainT supply chain…

Newsletters February 6, 2019

No. 378: Applied DNA in Asia, tech in the classroom and golfers on the moon (plus: why King Kullen still cares)

  Stuck in the middle with you: Here we are, dear reader, together again at the midpoint of another busy week of socioeconomic innovation. Welcome to Wednesday! It’s Feb. 6 out there, marking both Ronald Reagan Day in California (where the future president served two terms as governor) and the UN’s International Day of Zero Tolerance for Female Genital Mutilation, which is no joke. Sick days: Before we get started, yes, you have the flu…

Biotech February 4, 2019

Globetrotting Applied DNA has it made in Taiwan

By GREGORY ZELLER // Look out, Asia – here comes Applied DNA Sciences. Picking up where it left off at the end of a hyper-busy 2018 – in which it expanded its DNA-based supply-chain-authentication portfolio to include pharmaceuticals manufacturing in Pennsylvania, legalized marijuana distribution in Canada and a host of other supply chains in domestic and international markets – the Stony Brook-based biotech is sending its product-traceability solutions deep into to “the heart of Asia’s…

Newsletters December 14, 2018

No: 365: Electrons, hackathons, gadget gifts and yes, America, there is a climate change

  Golden mettle: Congratulations, dear reader – you’ve reached the 50th Friday of 2018 (go ahead and count, if you don’t believe us) and the end of another busy week of socioeconomic innovation. You are to be commended. It’s Dec. 14 out there, and we have plenty of interesting days to choose from – it’s international Monkey Day and, here in the USA, National Salesperson Day. Because it just sounds so badass: But we’re going…

Newsletters October 31, 2018

No. 353: Don’t be scared, it’s just our Halloween edition (featuring spacemen, blood machines and ghost chickens)

  In the spirit: Welcome to Wednesday, fearless readers, the midpoint of another busy week of socioeconomic innovation and the start of another holiday season. It is, of course, Oct. 31, a date that needs no introduction – though whether Halloween is a pagan ritual dating back to Celtic Druids, as many believe, or actually a Christian creation is open to some debate. Boo: Either way, the first jack-o-lanterns were made from turnips, the fear…

Biotech October 30, 2018

Applied DNA makes its bed, U.S. retailers to jump in

By GREGORY ZELLER // Inspired by Applied DNA Sciences’ molecular-tagging technology, a global textiles manufacturer is climbing into bed with the “circular economy.” Actually, India-based GHCL Ltd. has already bedded the so-called circular economy (referencing a regenerative system in which waste and emissions are minimized by narrowing energy and material loops, mostly through recycling and manufacturing upgrades). The manufacturer is knee-deep in recycled materials, including entire linen lines formulated from recycled polyethylene terephthalate (you may…

Biotech October 16, 2018

At LineaRX, putting the horsepower behind the CAR T

By GREGORY ZELLER // Marking a big step in the war against cancer, a Stony Brook-based startup has initiated pre-clinical development of a non-viral, plasmid-free chimeric antigen receptor modified T-cell manufacturing platform. In English: A novel platform designed to develop and manufacture new pharmaceutical treatments, including treatments for different forms of cancer. The tech comes from LineaRx Inc., a wholly owned subsidiary that officially spun off from Stony Brook-based Applied DNA Sciences in September. Noting…